Related references
Note: Only part of the references are listed.m6A transferase METTL3-induced lncRNA ABHD11-AS1 promotes the Warburg effect of non-small-cell lung cancer
Lei Xue et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2021)
Tumor necrosis factor In lung cancer: Complex roles in biology and resistance to treatment
Ke Gong et al.
NEOPLASIA (2021)
Lung Cancer 2020 Epidemiology, Etiology, and Prevention
Brett C. Bade et al.
CLINICS IN CHEST MEDICINE (2020)
LncRNA DLGAP1-AS2 modulates glioma development by up-regulating YAP1 expression
Wei Miao et al.
JOURNAL OF BIOCHEMISTRY (2020)
A TP53-associated gene signature for prediction of prognosis and therapeutic responses in lung squamous cell carcinoma
Feng Xu et al.
ONCOIMMUNOLOGY (2020)
The value of CEP55 gene as a diagnostic biomarker and independent prognostic factor in LUAD and LUSC
Linhai Fu et al.
PLOS ONE (2020)
Rationale for Lung Adenocarcinoma Prevention and Drug Development Based on Molecular Biology During Carcinogenesis
Hongming Zhang et al.
ONCOTARGETS AND THERAPY (2020)
Cancer burden of major cancers in China: A need for sustainable actions
Maomao Cao et al.
CANCER COMMUNICATIONS (2020)
Non-coding RNA profile in lung cancer
Soudeh Ghafouri-Fard et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2020)
A signature of immune-related gene pairs predicts oncologic outcomes and response to immunotherapy in lung adenocarcinoma
Feng Xu et al.
GENOMICS (2020)
N6-Methylandenosine-Related lncRNAs Are Potential Biomarkers for Predicting the Overall Survival of Lower-Grade Glioma Patients
Zewei Tu et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Development of a five-protein signature for predicting the prognosis of head and neck squamous cell carcinoma
Xinyuan Zhao et al.
AGING-US (2020)
Identification and validation of stemness-related lncRNA prognostic signature for breast cancer
Xiaoying Li et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
Immune-Related lncRNA to Construct Novel Signature and Predict the Immune Landscape of Human Hepatocellular Carcinoma
Weifeng Hong et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
A Seven Immune-Related lncRNAs Model to Increase the Predicted Value of Lung Adenocarcinoma
Jian-Ping Li et al.
FRONTIERS IN ONCOLOGY (2020)
DNA methylation-based lung adenocarcinoma subtypes can predict prognosis, recurrence, and immunotherapeutic implications
Feng Xu et al.
Aging-US (2020)
A Competing Endogenous RNA Network Reveals Novel lncRNA, miRNA and mRNA Biomarkers With Diagnostic and Prognostic Value for Early Breast Cancer
Zhong-Bing Luo et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2020)
Long non-coding RNA FEZF1-AS1 facilitates non-small cell lung cancer progression via the ITGA11/miR-516b-5p axis
Heng Song et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2020)
Identification of gene expression profiles and immune cell infiltration signatures between low and high tumor mutation burden groups in bladder cancer
Zonglong Wu et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2020)
Distinct Patterns of mRNA and lncRNA Expression Differences Between Lung Squamous Cell Carcinoma and Adenocarcinoma
Yingxuan Tian et al.
JOURNAL OF COMPUTATIONAL BIOLOGY (2020)
Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma
Qian Song et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
The role of m6A RNA methylation in cancer
Ting Sun et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Interplay Between N6-Methyladenosine (m6A) and Non-coding RNAs in Cell Development and Cancer
Francesco Fazi et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
Genomic Landscape and Immune Microenvironment Features of Preinvasive and Early Invasive Lung Adenocarcinoma
Chao Zhang et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
LncRNA DGCR5 promotes lung adenocarcinoma (LUAD) progression via inhibiting hsa-mir-22-3p
Hui-Xing Dong et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018
J. Ferlay et al.
EUROPEAN JOURNAL OF CANCER (2018)
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
Peng Jiang et al.
NATURE MEDICINE (2018)
Link Between m6A Modification and Cancers
Zhen-Xian Liu et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2018)
Implementing tumor mutational burden (TMB) analysis in routine diagnostics-a primer for molecular pathologists and clinicians
Michael Allgaeuer et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2018)
Immune-based Therapies for Non-small Cell Lung Cancer
Hind Rafei et al.
ANTICANCER RESEARCH (2017)
N6-Methyladenosine Modification in a Long Noncoding RNA Hairpin Predisposes Its Conformation to Protein Binding
Katherine I. Zhou et al.
JOURNAL OF MOLECULAR BIOLOGY (2016)
NK Cell Subtypes as Regulators of Autoimmune Liver Disease
Guohui Jiao et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2016)
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
Suzanne L. Topalian et al.
NATURE REVIEWS CANCER (2016)
Functions of lncRNA HOTAIR in lung cancer
Gregory Loewen et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2014)
Share Paper
